PL335652A1 - Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid - Google Patents
Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acidInfo
- Publication number
- PL335652A1 PL335652A1 PL98335652A PL33565298A PL335652A1 PL 335652 A1 PL335652 A1 PL 335652A1 PL 98335652 A PL98335652 A PL 98335652A PL 33565298 A PL33565298 A PL 33565298A PL 335652 A1 PL335652 A1 PL 335652A1
- Authority
- PL
- Poland
- Prior art keywords
- phenylprolidin
- ylidenomethyl
- indolo
- dichloro
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9704498.6A GB9704498D0 (en) | 1997-03-05 | 1997-03-05 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL335652A1 true PL335652A1 (en) | 2000-05-08 |
Family
ID=10808697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98335652A PL335652A1 (en) | 1997-03-05 | 1998-03-03 | Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0966463A1 (is) |
| JP (1) | JP2001513796A (is) |
| KR (1) | KR20000075907A (is) |
| CN (1) | CN1249750A (is) |
| AP (1) | AP9901637A0 (is) |
| AR (1) | AR011178A1 (is) |
| AU (1) | AU6825198A (is) |
| BG (1) | BG103779A (is) |
| BR (1) | BR9808305A (is) |
| CA (1) | CA2282851A1 (is) |
| CO (1) | CO4940415A1 (is) |
| EA (1) | EA199900710A1 (is) |
| EE (1) | EE9900387A (is) |
| GB (1) | GB9704498D0 (is) |
| HR (1) | HRP980114A2 (is) |
| HU (1) | HUP0002109A2 (is) |
| ID (1) | ID24207A (is) |
| IL (1) | IL131489A0 (is) |
| IS (1) | IS5166A (is) |
| NO (1) | NO994303L (is) |
| NZ (1) | NZ337315A (is) |
| OA (1) | OA11154A (is) |
| PE (1) | PE51399A1 (is) |
| PL (1) | PL335652A1 (is) |
| SK (1) | SK119699A3 (is) |
| TR (1) | TR199902117T2 (is) |
| WO (1) | WO1998039327A1 (is) |
| YU (1) | YU43499A (is) |
| ZA (1) | ZA981791B (is) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9704499D0 (en) * | 1997-03-05 | 1997-04-23 | Glaxo Wellcome Spa | Method of manufacture |
| GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| MX393950B (es) | 2017-06-12 | 2025-03-24 | Glytech Llc | Composicion y metodo para el tratamiento de la depresion y psicosis en humanos |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9321221D0 (en) * | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-03-05 GB GBGB9704498.6A patent/GB9704498D0/en active Pending
-
1998
- 1998-03-03 PE PE1998000149A patent/PE51399A1/es not_active Application Discontinuation
- 1998-03-03 EE EEP199900387A patent/EE9900387A/xx unknown
- 1998-03-03 AP APAP/P/1999/001637A patent/AP9901637A0/en unknown
- 1998-03-03 AR ARP980100948A patent/AR011178A1/es unknown
- 1998-03-03 EA EA199900710A patent/EA199900710A1/ru unknown
- 1998-03-03 SK SK1196-99A patent/SK119699A3/sk unknown
- 1998-03-03 IL IL13148998A patent/IL131489A0/xx unknown
- 1998-03-03 YU YU43499A patent/YU43499A/sh unknown
- 1998-03-03 CA CA002282851A patent/CA2282851A1/en not_active Abandoned
- 1998-03-03 KR KR1019997007987A patent/KR20000075907A/ko not_active Withdrawn
- 1998-03-03 HU HU0002109A patent/HUP0002109A2/hu unknown
- 1998-03-03 CN CN98803053A patent/CN1249750A/zh active Pending
- 1998-03-03 EP EP98913613A patent/EP0966463A1/en not_active Withdrawn
- 1998-03-03 JP JP53813598A patent/JP2001513796A/ja active Pending
- 1998-03-03 BR BR9808305-8A patent/BR9808305A/pt not_active Application Discontinuation
- 1998-03-03 PL PL98335652A patent/PL335652A1/xx unknown
- 1998-03-03 ZA ZA9801791A patent/ZA981791B/xx unknown
- 1998-03-03 TR TR1999/02117T patent/TR199902117T2/xx unknown
- 1998-03-03 NZ NZ337315A patent/NZ337315A/en unknown
- 1998-03-03 AU AU68251/98A patent/AU6825198A/en not_active Abandoned
- 1998-03-03 WO PCT/EP1998/001146 patent/WO1998039327A1/en not_active Ceased
- 1998-03-03 CO CO98011404A patent/CO4940415A1/es unknown
- 1998-03-03 ID IDW990976A patent/ID24207A/id unknown
- 1998-03-04 HR HR9704498.6A patent/HRP980114A2/hr not_active Application Discontinuation
-
1999
- 1999-08-27 IS IS5166A patent/IS5166A/is unknown
- 1999-09-02 OA OA9900201A patent/OA11154A/fr unknown
- 1999-09-03 NO NO994303A patent/NO994303L/no not_active Application Discontinuation
- 1999-10-04 BG BG103779A patent/BG103779A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20000075907A (ko) | 2000-12-26 |
| CA2282851A1 (en) | 1998-09-11 |
| GB9704498D0 (en) | 1997-04-23 |
| AP9901637A0 (en) | 1999-09-30 |
| HUP0002109A2 (hu) | 2001-04-28 |
| CO4940415A1 (es) | 2000-07-24 |
| NO994303L (no) | 1999-11-03 |
| IS5166A (is) | 1999-08-27 |
| ZA981791B (en) | 1999-09-03 |
| IL131489A0 (en) | 2001-01-28 |
| AU6825198A (en) | 1998-09-22 |
| NO994303D0 (no) | 1999-09-03 |
| HRP980114A2 (en) | 1998-12-31 |
| NZ337315A (en) | 2001-02-23 |
| EA199900710A1 (ru) | 2000-04-24 |
| BG103779A (en) | 2000-06-30 |
| JP2001513796A (ja) | 2001-09-04 |
| EP0966463A1 (en) | 1999-12-29 |
| SK119699A3 (en) | 2000-05-16 |
| ID24207A (id) | 2000-07-13 |
| AR011178A1 (es) | 2000-08-02 |
| EE9900387A (et) | 2000-04-17 |
| YU43499A (sh) | 2000-12-28 |
| PE51399A1 (es) | 1999-06-07 |
| BR9808305A (pt) | 2000-05-16 |
| TR199902117T2 (xx) | 2000-03-21 |
| WO1998039327A1 (en) | 1998-09-11 |
| CN1249750A (zh) | 2000-04-05 |
| OA11154A (en) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG24224A (en) | Omeprazole sodium salt | |
| PL345205A1 (en) | New 3-aryl-2-hydroxypropionic acid derivative (i) | |
| EG23980A (en) | Potassium salt of (s)-omeprazole | |
| IL139470A0 (en) | Oxyiminoalkanoic acid derivatives | |
| HUP0003881A3 (en) | Amidocarboxylic acid derivatives | |
| IL140358A0 (en) | Aminomethylarboxylic acid derivatives | |
| PL339659A1 (en) | Crystalline antimycotic polymorph | |
| AP2001002078A0 (en) | Crystalline forms of et02c-ch2(r)cgl-aze-pab-oh | |
| ZA957188B (en) | Use of 5-substituted pyridine- and hexahydroquinoline-3-carboxylic acid derivatives | |
| AU1917899A (en) | Crystalline sodium phenytoin monohydrate | |
| MXPA00012647A (es) | Derivados n-sustituidos de acido 5-oxiiminobarbiturico. | |
| HUP9801924A3 (en) | Combination containing sodium/hydrogen exchange inhibitors | |
| PL340461A1 (en) | Derivatives of isothiazocarboxylic acid | |
| AP9901457A0 (en) | Novel dihydroxyexanoic acid derivatives | |
| ITMI20000774A0 (it) | Cartuccia per la perforazione dell'orecchio | |
| AU2674497A (en) | Crystallization of sodium carbonates using alcohols | |
| PL335652A1 (en) | Hydrogenated crystalline sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylprolidin-3-ylidenomethyl)-1h-indolo-2-carboxylic acid | |
| AU1817700A (en) | 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 | |
| ZA981972B (en) | 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives | |
| ZA200007084B (en) | Novel salts of N-tert-butylhydroxylamine. | |
| HK1022899A (en) | Crystalline hydrated sodium salt of (e)-4, 6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1h-indole-2-carboxylic acid | |
| AUPP355498A0 (en) | Salt poultice | |
| AU1719700A (en) | Selective inhibitors of mmp-12 | |
| SI0991641T1 (en) | Crystalline form of omeprazole sodium salt | |
| AU1874600A (en) | Homopiperazine derivatives as selective emopamil inhibitors |